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Background: Attempts have been made to use dynamic spirometry to deﬁne restrictive lung function, but
the deﬁnition of a restrictive spirometric pattern (RSP) varies between studies such as BOLD and
NHANES. The aim of this study was to estimate the prevalence and risk factors of RSP among adults in
northern Sweden based on different deﬁnitions.
Methods: In 2008e2009 a general population sample aged 21e86y within the obstructive lung disease
in northern Sweden (OLIN) studies was examined by structured interview and spirometry, and 726
subjects participated (71% of invited). The prevalence of RSP was calculated according to three different
deﬁnitions based on pre-as well as post-bronchodilator spirometry:
1) FVC < 80% & FEV1/FVC > 0.7
2) FVC < 80% & FEV1/FVC > LLN
3) FVC < LLN & FEV1/FVC > LLN
Results: The three deﬁnitions yielded RSP prevalence estimates of 10.5%, 11.2% and 9.4% respectively,
when based on pre-bronchodilator values. The prevalence was lower when based on post-bronchodilator
values, i.e. 7.3%, 7.9% and 6.6%. According to deﬁnition 1 and 2, the RSP prevalence increased by age, but
not according to deﬁnition 3. The overlap between the deﬁnitions was substantial. When corrected for
confounding factors, manual work in industry and diabetes with obesity were independently associated
with an increased risk for RSP regardless of deﬁnition.
Conclusions: The prevalence of RSP was 7e11%. The prevalence estimates differed more depending on
the choice of pre- compared to post-bronchodilator values than on the choice of RSP deﬁnition. RSP was,
regardless of deﬁnition, independently associated with manual work in industry and diabetes with
obesity.
© 2016 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).MI, Body Mass Index; BOLD,
Interval; ERS, European Res-
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Ltd. This is an open access article u1. Introduction
Restrictive lung function is deﬁned as reduced lung expansion
expressed as a decreased total lung capacity (TLC). It may reﬂect
several underlying conditions and diseases, such as interstitial lung
diseases, pleural effusions and disorders, thoracic deformities,
neuromuscular diseases, diaphragmatic disorders, obesity, heart
failure, pregnancy and pain [1]. Interstitial lung diseases comprise
more than 200 diagnoses including idiopathic pulmonary ﬁbrosis,
several pneumoconiosis, sarcoidosis and several other conditionsnder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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the prevalence of idiopathic pulmonary ﬁbrosis has been estimated
at about 0.1% or even less [4].
Attempts have beenmade to use dynamic spirometry to identify
restrictive lung function, using a low FVC and a normal FEV1/FVC
ratio as a deﬁnition of a restrictive lung function [5]. Dynamic
spirometry has limitations in identifying restrictive lung diseases
[6,7], but it can effectively exclude a restrictive disease when FVC is
normal and its speciﬁcity increases when the FEV1/FVC ratio is
taken into account [7,8]. Further, a recent review stresses the many
clinical, public health and eventually therapeutic implications of
identifying subjects with a restrictive spirometry pattern (RSP) [9],
since RSP is associated with high symptom burden, comorbidities
and adverse outcomes including mortality.
The estimates of prevalence of restrictive conditions based on
dynamic spirometry vary considerably, probably due to the various
deﬁnitions used as described in the recent review [9]. Most
commonly, ﬁxed thresholds such as FVC < 80% of predicted and a
FEV1/FVC ratio >0.7 have been utilized for the deﬁnition of RSP, but
other types of thresholds are gaining ground. Further, most studies
have used pre-bronchodilator (pre-BD) spirometry data for
deﬁning RSP, while in the Burden of Obstructive Lung Disease
(BOLD) study post-bronchodilator (post-BD) data were used [8].
Data from the US National Health and Nutrition Examination sur-
veys (NHANES) have presented consistent results with prevalence
of RSP on general population level varying from 5.4% to 9.2%
[10e14]. Prevalence estimates from other studies vary from 3% to
13% [15e19], while the prevalence among the BOLD centers vary
from 4% to upward of 50% [8]. Co-existing diseases such as diabetes,
obesity, cardiovascular and rheumatic diseases and other risk fac-
tors for RSP have been studied mainly in the US. To date, there are
no studies comparing different deﬁnitions of RSP based on both
pre- and post-BD spirometry in the general population.
The aim of this studywas to estimate the prevalence of RSP in an
adult general population using different deﬁnitions of restrictive
spirometry, and to study associated risk factors and co-existing
diseases.
2. Materials and methods
2.1. Study population
In 2006 a random sample in ages 20e69 years in Norrbotten
county in Northern Sweden, n ¼ 7997, was invited to participate in
a postal questionnaire survey [20]. Another randomly selected
population sample in ages 30e84 years, which had participated in a
similar questionnaire survey in 1996 [21], was also invited,
n ¼ 7004. Overall 12,055 subjects (80% of the invited) participated
[22].
Of the questionnaire responders, a randomly selected sample,
n ¼ 1016, after stratiﬁcation for the sex and age distribution of the
county population, was invited to clinical examinations including
pre- and post-bronchodilator (BD) spirometry and a structured
interview in 2008e2009. Of the invited, 726 (71.5%) subjects per-
formed spirometry with adequate technique and completed the
interview [22], with mean age 53 years (range 21e86 years) and
50% women. The participants at the clinical examinations were
representative for the entire cohort with respect to age, gender and
prevalence of respiratory symptoms and diseases and their
comorbidities [23]. The Study was approved by the Regional Ethical
Review Board at Umeå University.
2.2. Questionnaire
The questionnaire consists of a self-administrated short versionfor postal surveys [24] and a version for interviews [25]. It has been
used in several epidemiological studies [26e29] and is validated
against the GA2LEN questionnaire [30]. The questions are focused
on respiratory symptoms and diseases, their comorbidities, allergy,
medication, family history of asthma and allergic diseases, smoking
habits, occupation, area of domicile and other potential risk factors
for respiratory diseases.
2.3. Spirometry
A Masterscope (Jaeger, Germany) ﬂow-volume spirometer was
used. The procedure followed the ATS/ERS recommendations [31]
but with a reproducibility criterion of 5% deviation from the
second highest value [32]. At least three and maximum six forced
vital capacity (FVC) maneuvers were performed. A reversibility test
was performed using 0.4 mg salbutamol powder via discus. Refer-
ence values for spirometry derived from the population living in
the study area were used [33]. The Global Lung Initiative (GLI)
reference values [34] were used in sensitivity analyses presented in
the Results section and Table A.1.
2.4. Deﬁnitions
RSP was deﬁned as a decreased FVC in combination with a
normal or increased FEV1/FVC ratio. The deﬁnitions thereof are
based both on ﬁxed thresholds, i.e. FVC < 80% of predicted and ratio
of FEV1/FVC > 0.7, and also on the lower limit of normal (LLN), i.e.
the ﬁfth percentile (approximately corresponding to a Z-
score < 1.645). Both pre- and post-BD spirometry was used,
where post-BD values were deﬁned as the highest of pre- and post-
BD results. The use of LLN is strongly recommended by the ERS/ATS
task force on standardization of lung function testing [31]. Three
different deﬁnitions based on pre- and post-BD values respectively
were analyzed (Table 1). Severity grading was based both on the
level of FEV1 as recommended by the ERS/ATS task force [31] and on
the level of FVC, and the limit for severity was deﬁned as <70% of
predicted for both. Subjects with obstructive spirometry were
excluded from analyses comparing RSP with normal spirometry.
Information about heart diseases, hypertension, diabetes and
rheumatic disease was collected through interviews. Ischemic heart
disease (IHD) was deﬁned as a history of myocardial infarction,
coronary artery bypass surgery, percutaneous coronary interven-
tion or angina pectoris. Any heart diseasewas deﬁned as a report of
IHD, heart failure, arrhythmia or other heart disease. Height and
weight was measured and Body Mass Index (BMI, kg/m2) calcu-
lated. Underweight was classiﬁed as BMI < 20, normal weight as
20  BMI < 25, overweight as 25  BMI < 30 and obesity as
BMI  30. The classiﬁcation of socio-economic status was based on
occupation. Smoking habits were classiﬁed as ever-smokers (cur-
rent or ex-smokers) and never-smokers, and by number of pack-
years. Ex-smokers were deﬁned as those who had smoked for at
least one year but not during the last 12 months.
2.5. Analyses
The Fisher's exact test (two-sided) was used for bivariate com-
parisons of proportions. For comparisons of proportions across
more than two groups, Mantel-Haenszel test for trend was used. A
p-value <0.05 was considered statistically signiﬁcant. Multiple lo-
gistic regression was used to test independent risk factors for RSP
with results presented as adjusted odds ratios (OR) with 95% con-
ﬁdence intervals (CI). Variables signiﬁcantly associated with RSP in
unadjusted analyses (Table A.2) were included in the regression
analyses. An interaction term between diabetes and obesity was
also analyzed. Age was dichotomized in the regression analyses
Table 1
Deﬁnitions of restrictive spirometric pattern (RSP).
Deﬁnition 1a Deﬁnition 2a Deﬁnition 3a
Normal spirometry FVC > 80% pred & FEV1/FVC > 0.7 FVC > 80% pred & FEV1/FVC > LLN FVC > LLN & FEV1/FVC > LLN
Restrictive spirometric pattern FVC < 80% pred & FEV1/FVC > 0.7 FVC < 80% pred & FEV1/FVC > LLN FVC < LLN & FEV1/FVC > LLN
Obstructive spirometry FEV1/FVC < 0.7 FEV1/FVC < LLN FEV1/FVC < LLN
pred ¼ predicted.
LLN ¼ Lower limit of Normal deﬁned as the ﬁfth percentile [31].
a Deﬁnitions 1e3 are analyzed based on both pre-bronchodilator and post-bronchodilator values, respectively.
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increases from middle ages.
3. Results
3.1. Participation and basic characteristics
Of the invited 504 women and 512 men, 73% and 70%, partici-
pated. Current smoking was more common among women, 17.7%,
than amongmen,11.8% (p¼ 0.028). In contrast, men tended to have
more pack-years than women. Among women, 24.2% were obese
versus 19.0% among men (p¼ 0.104), while the inverse was true for
overweight. The prevalence of both pre- and post-BD FVC < 80%
increased considerably by age, but less so for FVC < LLN (Table 2).
3.2. Prevalence and severity of restrictive spirometric pattern
The prevalence of pre-BD RSP was highest based on the
FVC < 80% & FEV1/FVC > LLN deﬁnition, 11.2%, while it was 10.5% for
FVC < 80% & FEV1/FVC > 0.7, and 9.4% for FVC < LLN & FEV1/
FVC > LLN. The prevalence based on post-BD spirometry followed
the same pattern but was lower, ranging from 7.9 to 6.6% (Table 3).
The prevalence of RSP increased by age and was most common in
age >60 years according to all deﬁnitions, except for the post-BD
FVC < LLN & FEV1/FVC > LLN deﬁnition. Further, pre-BD RSP ten-
ded to be somewhat more common among men (Table 3). There
was a considerable overlap between all three pre-BD deﬁnitions as
well as between all three post-BD deﬁnitions of RSP (Table 4). The
proportion among subjects with post-BD RSP with higher pre- than
post-BD values of FVC and FEV1/FVC was approximately 1/3 and of
FEV1 approximately 1/5 (Table A.3). Approximately 25% of the
subjects with pre-BD RSP had FVC < 70% of predicted (Fig. 1), whileTable 2
Participant characteristics by age group and sex.
Participant characteristics Sex
Women Men P-value
N ¼ 368 N ¼ 358
Never-smokers 49.9% 53.5%
Ex-smokers 32.4% 34.7%
Smokers 17.7% 11.8% 0.076
Never-smokers 49.9% 53.5%
Pack-years < 10 26.4% 21.0%
10  Pack-years < 20 13.4% 8.1%
Pack-years  20 10.4% 17.4% 0.519
Normal or underweight 37.0% 26.3%
Overweight 38.9% 54.7%
Obesity 24.2% 19.0% 0.057
Pre-bronchodilator FVC < 80% 10.9% 13.4% 0.308
Post-bronchodilator FVC < 80% 8.4% 8.7% 1.000
Pre-bronchodilator FVC < LLN 9.5% 11.5% 0.399
Post-bronchodilator FVC < LLN 7.1% 7.5% 0.887
P-value ¼ Fisher's exact test or Mantel Haenzel test for trend, as appropriate.
Pack-years represent smoking history among ever-smokers.
Two subjects lack information regarding smoking history.approximately 10e12% had FEV1 < 70% of predicted.
3.3. Symptoms associated with restrictive spirometric pattern
Most respiratory symptoms were more common among sub-
jects with RSP than among subjects with normal spirometry. In
general, the prevalence of symptoms was of similar magnitude
for the pre- and post-BD deﬁnitions of RSP. The most common
symptoms among the subjects with RSP were any wheeze last
12 months, 41.7%e46.1%, and sputum production, 37.5%e44.7%
(Table A.4). The greatest relative differences in symptomprevalence
were found for dyspnea, mMRC grades 2 and 3, which were
2.1e7.8 times more common among subjects with RSP than among
subjects with normal spirometry.
3.4. Risk factors
In unadjusted analyses, diabetes (OR 4.3e5.3), any heart disease
(OR 2.0e2.7) and obesity (OR 2.0e2.6) were signiﬁcantly associated
with RSP by all pre-BD deﬁnitions. Neither male sex nor ever
smoking was signiﬁcantly associated with RSP (Table A.2).
In adjusted analyses, the socio-economic group manual work in
industry was signiﬁcantly and independently associated with RSP
regardless of deﬁnitionwith ORs ranging from 1.76 to 3.10 (Tables 5
and 6). Diabetes yielded high and signiﬁcant odds ratios in the three
pre-BD analyses, varying from 2.39 to 3.16. Age >60 years was
signiﬁcantly associated with the pre-BD FVC < 80%& FEV1/FVC > 0.7
and FVC < 80% & FEV1/FVC > LLN deﬁnitions of RSP, while it was not
with the FVC < LLN & FEV1/FVC > LLN deﬁnition. Current smoking,
hypertension and obesity were signiﬁcantly associated with some
deﬁnitions. Neither rheumatic disease nor any heart disease was
independently associated with any of the RSP deﬁnitions.Age group All
22e40y 41e60y 61e84y P-value
N ¼ 167 N ¼ 312 N ¼ 247 N ¼ 726
70.7% 45.7% 46.3% 51.7%
15.6% 37.9% 40.2% 33.6%
13.8% 16.4% 13.4% 0.003 13.4%
70.7% 45.7% 46.3% 51.7%
25.7% 25.1% 20.7% 23.8%
3.0% 16.1% 9.3% 10.8%
0.6% 13.2% 23.6% <0.001 13.8%
35.9% 34.6% 25.1% 31.7%
44.3% 44.2% 51.4% 46.7%
19.8% 21.2% 23.5% 0.018 21.6%
7.2% 8.3% 20.2% <0.001 12.1%
6.0% 5.8% 13.8% 0.002 8.5%
7.8% 9.0% 14.2% 0.027 10.5%
7.8% 5.8% 8.9% 0.547 7.3%
Table 3
Prevalence of restrictive spirometric pattern (RSP) by age group and sex, according to three different deﬁnitions based on pre- and post-bronchodilator spirometry.
Deﬁnition of RSP Sex Age group All
Women Men P-value 22e39y 40e60y 61e84y P-value
FVC < 80% & FEV1/FVC > 0.7 pre 9.0% 12.0% 0.185 7.2% 8.0% 15.8% 0.003 10.5%
post 7.1% 7.5% 0.887 6.0% 5.4% 10.5% 0.053 7.3%
FVC < 80% & FEV1/FVC > LLN pre 10.3% 12.0% 0.482 7.2% 8.0% 17.8% <0.001 11.2%
post 8.2% 7.5% 0.784 6.0% 5.4% 12.1% 0.011 7.9%
FVC < LLN & FEV1/FVC > LLN pre 8.7% 10.1% 0.611 7.8% 8.3% 11.7% 0.147 9.4%
post 6.8% 6.4% 0.882 7.8% 5.4% 7.3% 0.954 6.6%
P-value ¼ Fisher's exact test or Mantel Haenzel test for trend, as appropriate.
pre ¼ based on pre-bronchodilator spirometry.
post ¼ based on post-bronchodilator spirometry.
Table 4
Overlap (n) between different deﬁnitions of restrictive spirometric pattern (RSP).
Deﬁnition of RSP Prevalence Overlap (n)
pre post
FVC < 80% &
FEV1/FVC > 0.7
FVC < 80% &
FEV1/FVC > LLN
FVC < LLN &
FEV1/FVC > LLN
FVC < 80% &
FEV1/FVC > 0.7
FVC < 80% &
FEV1/FVC > LLN
FVC < LLN &
FEV1/FVC > LLN
n (%) 76 (10.5%) 81 (11.2%) 68 (9.4%) 53 (7.3%) 57 (7.9%) 48 (6.6%)
pre FVC < 80% & FEV1/FVC > 0.7 76 (10.5%) 76 * * * * *
FVC < 80% & FEV1/FVC > LLN 81 (11.2%) 76 81 * * * *
FVC < LLN & FEV1/FVC > LLN 68 (9.4%) 60 64 68 * * *
post FVC < 80% & FEV1/FVC > 0.7 53 (7.3%) 52 53 46 53 * *
FVC < 80% & FEV1/FVC > LLN 57 (7.9%) 53 57 50 53 57 *
FVC < LLN & FEV1/FVC > LLN 48 (6.6%) 44 47 48 39 42 48
pre ¼ based on pre-bronchodilator spirometry.
post ¼ based on post-bronchodilator spirometry.
RSP ¼ Restrictive spirometric pattern.
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without obesity nor obesity without diabetes was signiﬁcantly asso-
ciated with any RSP deﬁnition, diabetes with obesity yielded high
and signiﬁcant adjusted ORs for all six deﬁnitions of RSP, ranging
from 5.38 to 7.81 (Fig. 2).
3.5. Sensitivity analyses
When the GLI reference values were applied, the estimates of
RSP prevalence were low. The pre- and post-BD prevalence esti-
mates varied from 2.8% to 4.7% and from 2.1% to 2.9%, respectively
(Table A.1). In adjusted risk analyses, manual work in industry was
signiﬁcantly associated with RSP irrespectively how RSP was
deﬁned (OR 2.89e5.13), and so was hypertension (OR 2.83e3.69).
Similar to when the OLIN reference values were used, neither
obesity without diabetes nor diabetes without obesitywas associated
with RSP, while diabetes with obesity yielded ORs from 1.87 to 18.79.
4. Discussion
The prevalence of restrictive spirometric pattern (RSP) was
9e11% when based on pre-BD values, which is the most commonly
used deﬁnition of RSP [7,9e18]. Use of post-BD values yielded a
prevalence of 7e8%. The overlap between the different deﬁnitions
was substantial.
The prevalence increased by age in line with previous results
from the NHANES [10,11], however, not signiﬁcantly using the
FVC < LLN & FEV1/FVC > LLN deﬁnition of RSP. No signiﬁcant gender
differences were found.
The prevalence of the pre-BD FVC < 80% & FEV1/FVC > 0.7 deﬁ-
nition, 10.7%, is similar to the 8e12% reported from the NHANES I
[10], two other studies from the USA [15,17], and one from Italy [16],
but somewhat higher than the 6.5e7.6% found in the NHANES III1988e1994 and the NHANES 2007e2010 [13].
The data from the NHANES III 1988e1994 and NHANES
2007e2010 have also been analyzed using the FVC < LLN & FEV1/
FVC > LLN deﬁnition [14] which yielded a prevalence of 7.2% in the
NHANES III and 5.4% in the latter survey. These results are similar to
the 7.6% and 6.5%, respectively, which the NHANES found based on
the most commonly used deﬁnition, i.e. FVC < 80%& FEV1/FVC > 0.7
[13]. These studies suggest some decrease in prevalence of RSP in
USA over the 15e20 year period.
Most studies deﬁne RSP as a decreased pre-BD FVC and a normal
or elevated FEV1/FVC ratio. A Spanish multi-center study using this
deﬁnition based on the ECSC reference values yielded prevalence
estimates ranging from 5% to 19% between sites [19]. The BOLD
study [8] used a deﬁnition of FEV1 < 80% and FEV1/FVC > 0.7 based
on post-BD spirometry. The NHANES reference values were used for
all centers in the BOLD study and yielded a large variance in
prevalence; from 4e8% in Australia and 5e6% in Vancouver to
upwards 50% in the Philippines and India [8]. ATS/ERS presents a
severity classiﬁcation for restrictive subjects based on FEV1% of
predicted [31], and 10e12% of those with RSP had FEV1<70% of
predicted in our study. We argue, however, that severity of
restrictive lung disease could be based on FVC because it limits
possible misclassiﬁcation of volume-responders as being restrictive
and the fact that restriction itself is deﬁned as a reduction of the
lung volume.
In unadjusted analyses the co-morbid conditions diabetes and
heart disease were most consistently associated with RSP. In
adjusted analyses, only the association between pre-BD RSP and
diabetes remained. An association between RSP and heart diseases
has been found in several NHANES surveys [10e14], the BOLD study
[8] and some other studies [15,17,18]. In line with our results, an
association with diabetes was found in both the BOLD [8] and
NHANES [11,12,14] studies. The NHANES and BOLD studies have
Fig. 1. Histograms of pre-bronchodilator FVC % of predicted among subjects with restrictive spirometric pattern according to the three different deﬁnitions.
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Table 5
Risk factors for pre-bronchodilator restrictive spirometric pattern (RSP) according to different deﬁnitions (adjusted analyses).
FVC < 80% & FEV1/FVC > 0.7 FVC < 80% & FEV1/FVC > LLN FVC < LLN & FEV1/FVC > LLN
OR (95% CI) OR (95% CI) OR (95% CI)
Age > 60 years 1.97 (1.14e3.42) 1.89 (1.11e3.23) 0.95 (0.52e1.72)
Current smoking 1.71 (0.85e3.44) 1.73 (0.88e3.41) 2.27 (1.14e4.52)
Manual work in industry 1.89 (1.07e3.34) 1.76 (1.00e3.09) 2.16 (1.21e3.88)
Any heart disease 1.60 (0.84e3.04) 1.47 (0.79e2.74) 1.44 (0.72e2.87)
Rheumatic disease 2.11 (0.81e5.52) 1.65 (0.65e4.21) 1.69 (0.62e4.59)
Hypertension 1.55 (0.89e2.72) 1.61 (0.93e2.76) 2.16 (1.20e3.90)
Obesity 1.52 (0.87e2.65) 1.55 (0.90e2.66) 1.14 (0.63e2.08)
Diabetes 2.39 (1.08e5.27) 3.02 (1.44e6.36) 3.16 (1.42e7.02)
OR ¼ Odds Ratio from multiple logistic regression models, CI ¼ Conﬁdence Interval.
Subjects with normal spirometry as reference.
Signiﬁcant associations are bolded.
Table 6
Risk factors for post-bronchodilator restrictive spirometric pattern (RSP) according to different deﬁnitions (adjusted analyses).
FVC < 80% & FEV1/FVC > 0.7 FVC < 80% & FEV1/FVC > LLN FVC < LLN & FEV1/FVC > LLN
OR (95% CI) OR (95% CI) OR (95% CI)
Age > 60y 1.79 (0.94e3.42) 1.83 (0.98e3.41) 0.88 (0.44e1.76)
Current smoking 2.51 (1.34e4.72) 2.44 (1.32e4.51) 1.87 (0.96e3.64)
Manual work in industry 2.77 (1.16e6.58) 3.10 (1.37e7.05) 2.62 (1.04e6.60)
Any heart disease 1.18 (0.55e2.57) 1.19 (0.57e2.51) 0.92 (0.39e2.20)
Rheumatic disease 0.96 (0.26e3.55) 0.86 (0.23e3.18) 1.18 (0.33e4.25)
Hypertension 1.25 (0.65e2.41) 1.38 (0.73e2.58) 1.21 (0.61e2.40)
Obesity 1.90 (0.87e4.14) 2.08 (1.00e4.30) 1.65 (0.75e3.65)
Diabetes 1.61 (0.83e3.11) 1.54 (0.81e2.93) 1.91 (0.96e3.80)
OR ¼ Odds Ratio from multiple logistic regression models, CI ¼ Conﬁdence Interval.
Subjects with normal spirometry as reference.
Signiﬁcant associations are bolded.
Fig. 2. The risk for restrictive spirometric pattern among subjects with obesity without diabetes, diabetes without obesity, and diabetes with obesity. Odds Ratios with
neither obesity nor diabetes as reference, adjusted for age, any heart disease, rheumatic disease, hypertension, manual work in industry, and smoking. BD ¼ bronchodilator.
*Diabetes with obesity was a signiﬁcant risk factor (p < 0.05) regardless of deﬁnition of RSP.
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[8,11]. Although we found an interaction between obesity and
diabetes, our study did not ﬁnd obesity alone to be independentlyassociated with RSP.
Only a few studies have focused on risk factors for RSP on
population level. Among other risk factors, manual work in
H. Backman et al. / Respiratory Medicine 120 (2016) 116e123122industry was signiﬁcantly and independently associated with RSP
regardless of deﬁnition and choice of reference values. The found
association is of great interest, as early interstitial or pleural
involvement without a clinical disease might be caused by occu-
pational exposures [35]. However, among Swedish construction
workers, the prevalence of restrictive lung function was only 4%
[36]. As found by others [11,16], age was signiﬁcantly associated
with RSP when the condition was based on the FVC < 80% & FEV1/
FVC > 0.7 deﬁnition, but not when the FVC < LLN & FEV1/FVC > LLN
deﬁnition was applied.
The impact of reference values for interpretation of spirometry
ﬁndings is exempliﬁed by use of the GLI reference values [34],
which in our study population resulted in considerably lower
prevalence of RSP. The reason for the large difference in prevalence
is that the GLI reference values for FVC results in lower FVC pre-
dictions than the reference values for the population under study
[37]. The choice of reference values may at least in part explain the
low prevalence of RSP, i.e. 3e4%, found in previous Swedish studies
[18,36]. Also the recent review on RSP notes that discrepancies in
RSP prevalence may be attributable to use of different reference
values [9].
Assessment of total lung capacity (TLC) is the best test to
correctly differentiate restrictive lung function from normal and
obstructive lung function. However, there is a lack in the literature
of more recent studies focusing on TLC in the general population.
The normal range has been estimated as quite wide, as exempliﬁed
by an elderly consensus report [38] and by a study in Brazil [39]. A
few population studies have measured TLC, but have not focused
their publications directly on TLC [40]. Instead of focusing on TLC,
several studies have deﬁned restrictive lung function by use of
dynamic spirometry alone [8,10e13,15e18]. We have found only
one study that has validated this issue. The study found that about
60% of those with a RSP deﬁned as pre-BD FVC < 80% & FEV1/
FVC > 0.7 to have a true restrictive lung function deﬁned as a low
total lung capacity (TLC) [7]. Thus, the use of dynamic spirometry
leads to an overestimation of the prevalence of restrictive lung
function where air trapping in small airways contributes. On the
other hand, only 3% of thosewith FVC > 80% of predicted values had
a restrictive lung function deﬁned as a low TLC. Consequently, dy-
namic spirometry can effectively exclude subjects who are unlikely
to have restrictive lung function from undergoing costly examina-
tions of TLC [7].
This study is the ﬁrst to compare different deﬁnitions of RSP
based on both pre- and post-BD values. The high participation rate
contributes to the validity of the results. Repeated control of
methods has been performed with regular time intervals. Only
limited bias caused by non-response and non-participation has
been found [41]. The questionnaire has recently been validated
[30], and the staff of nurses and technicians is well trained. As
mentioned, dynamic spirometry has limitations in identifying
restrictive lung function. In case dynamic spirometry is used for
deﬁning RSP, we believe LLN results should be preferred as the use
of ﬁxed ratio overestimates the impact of age on the results. Also,
our results put emphasis on the use of post-bronchodilator
spirometry when deﬁning RSP as volume responders otherwise
could incorrectly be classiﬁed as having restriction. This assump-
tion is supported by the fact that an increase in the FEV1/FVC ratio
was observed in about 70% of the cases.
In conclusion, restrictive spirometric pattern is common with a
prevalence of 9e11% based on pre-bronchodilator values and 7e8%
based on post-bronchodilator values. The choice of reference values
affected the prevalence. Irrespective of deﬁnition, restrictive
spirometric pattern was independently associated with manual
work in industry and diabetes with obesity.Acknowledgements
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